HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Paranasal Sinus Cancer

Paranasal sinus cancer is a rare form of cancer that originates in the paranasal sinuses, which are air-filled spaces located within the bones of the face surrounding the nasal cavity. These sinuses play a crucial role in humidifying and filtering the air we breathe. While paranasal sinus cancer is uncommon, its impact can be significant. The exact cause of paranasal sinus cancer is not well understood, but certain risk factors may increase the likelihood of its development. These factors include exposure to certain workplace materials, such as wood dust or certain metals, as well as a history of chronic sinusitis or nasal polyps. Additionally, tobacco and alcohol use have been identified as potential risk factors. Symptoms of paranasal sinus cancer can be subtle in the early stages, making early detection challenging. Common signs include persistent nasal congestion, frequent nosebleeds, facial pain or numbness, and changes in vision or double vision. As the cancer progresses, individuals may also experience headaches, unintentional weight loss, and swelling or lumps on the face. Diagnosis typically involves a thorough examination by an ear, nose, and throat specialist, along with imaging studies such as CT scans or MRIs. A biopsy is often performed to confirm the presence of cancerous cells. Treatment options for paranasal sinus cancer depend on various factors, including the stage of the cancer, its location, and the overall health of the patient. Common approaches include surgery, radiation therapy, and sometimes chemotherapy. Prognosis varies, and the outlook for individuals with paranasal sinus cancer depends on factors such as the extent of the disease at the time of diagnosis and the effectiveness of treatment. Early detection and prompt intervention can significantly improve the chances of successful outcomes.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp